期刊文献+

黄连素对2型糖尿病湿热困脾证患者胰高血糖素样肽的影响 被引量:10

Effects of berberine on glucagon-like peptide in patients with type 2 diabetes mellitus(syndrome of dampness-heat disturbing spleen)
原文传递
导出
摘要 目的:探讨黄连素对2型糖尿病湿热困脾证患者的血糖、胰岛素抵抗及胰高血糖素样肽-1(glucagon-like-peptide-1,GLP-1)的影响。方法:纳入2型糖尿病湿热困脾证患者60例,随机分为对照组和黄连素组,每组各30例。两组患者均给予西医常规治疗,黄连素组患者在西医常规治疗的基础上加用黄连素口服,两组疗程均为12周。评价两组患者的临床疗效,检测两组患者的空腹血糖(FBG)、糖化血红蛋白(HbAlc)、胰岛素(FINS)及GLP-1水平,计算胰岛素抵抗指数(HOMA-IR)。结果:治疗后,黄连素组、对照组的临床总有效率分别为92.86%、72.41%,黄连素组疗效优于对照组(P<0.01)。治疗后,两组患者的FBG、HbAlc、FINS、HOMAIR水平较治疗前均明显降低(P<0.05),GLP-1水平较治疗前明显升高(P<0.05);且黄连素组患者的FBG、HbAlc、FINS、HOMA-IR水平低于对照组(P<0.05),GLP-1水平高于对照组(P<0.05)。结论:黄连素结合西医常规疗法治疗2型糖尿病湿热困脾证患者,可改善患者的临床症状,并能通过升高GLP-1水平控制血糖,改善胰岛素抵抗。 Objective: To explore the effects of berberine on blood glucose,insulin resistance and glucagon-like peptide-1( GLP-1)in patients with type 2 diabetes mellitus( syndrome of dampness-heat disturbing spleen). Methods: Sixty patients of type 2 diabetes mellitus with syndrome of dampness-heat disturbing spleen were selected and randomly divided into the control group and the berberine group,30 cases in each group. All patients were treated with routine western medicine,and the patients in the berberine group were orally treated with berberine on the basis of routine western medicine,with a course of 12 weeks. The clinical efficacy was evaluated,the levels of fasting blood glucose( FBG),glycated hemoglobin( HbAlc),fasting insulin( FINS) and GLP-1 were detected,and the insulin resistance index( HOMA-IR) was calculated. Results: After treatment,the total clinical effective rates of the berberine group and the control group were 92.86% and 72.41% respectively,and the efficacy of the berberine group was better than that of the control group( P<0.01). After treatment,the levels of FBG,HbAlc,FINS and HOMA-IR in both groups were significantly decreased compared with treatment before( P<0.05),the level of GLP-1 was significantly increased( P<0.05); and the levels of FBG,HbAlc,FINS and HOMA-IR in the berberine group were lower than those in the control group( P<0.05),and the level of GLP-1 in the berberine group was higher than that in the control group( P<0.05). Conclusion: Berberine combined with routine western medicine can improve the clinical symptoms of patients of type 2 diabetes mellitus with syndrome of dampness-heat disturbing spleen,and control the level of blood glucose and improve insulin resistance by raising the level of GLP-1.
作者 沙雯君 朱英倩 雷涛 SHA Wenjun;ZHU Yingqian;LEI Tao(Department of Endocrinology,Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 200062,China)
出处 《上海中医药大学学报》 CAS 2018年第6期7-10,共4页 Academic Journal of Shanghai University of Traditional Chinese Medicine
基金 国家自然科学基金青年科学基金项目(81704027) 上海市卫计委科研基金项目(201640206)
关键词 2型糖尿病 湿热困脾证 黄连素 胰高血糖素样肽-1 type 2 diabetes syndrome of dampness-heat disturbing spleen berberine GLP-I
  • 相关文献

参考文献2

二级参考文献18

  • 1Hideaki Kaneto,Taka-aki Matsuoka.Down-regulation of pancreatic transcription factors and incretin receptors in type 2 diabetes[J].World Journal of Diabetes,2013,4(6):263-269. 被引量:9
  • 2潘长玉,田慧,刘国良,李秀钧,傅祖植,陈家伟,暨亚洲糖尿病管理中国协作组.中国城市中心医院糖尿病健康管理调查[J].中华内分泌代谢杂志,2004,20(5):420-424. 被引量:193
  • 3潘长玉,中国区合作调查组.中国糖尿病控制现状——指南与实践的差距 亚洲糖尿病治疗现状调查1998,2001及2003年中国区结果介绍[J].国外医学(内分泌学分册),2005,25(3):174-178. 被引量:395
  • 4顾云娟,崔世维,朱湘竹,朱晓晖,王粹芳,印彤.南通地区2型糖尿病综合治疗情况调查[J].交通医学,2006,20(5):619-620. 被引量:2
  • 5Shiying Wu,Ingrid Hopper,Marina Skiba,Henry Krum.Dipeptidyl Peptidase‐4 Inhibitors and Cardiovascular Outcomes: Meta‐Analysis of Randomized Clinical Trials with 55,141 Participants[J].Cardiovasc Ther.2014(4)
  • 6Juris J. Meier,Michael A. Nauck.Risk of pancreatitis in patients treated with incretin-based therapies[J].Diabetologia.2014(7)
  • 7Sun H. Kim,Alice Liu,Danit Ariel,Fahim Abbasi,Cindy Lamendola,Kaylene Grove,Vanessa Tomasso,Gerald Reaven.Pancreatic beta cell function following liraglutide-augmented weight loss in individuals with prediabetes: analysis of a randomised, placebo-controlled study[J].Diabetologia.2014(3)
  • 8Sun H. Kim,Fahim Abbasi,Cindy Lamendola,Alice Liu,Danit Ariel,Patricia Schaaf,Kaylene Grove,Vanessa Tomasso,Hector Ochoa,Yeheng V. Liu,Yii-Der Ida Chen,Gerald Reaven.Benefits of Liraglutide Treatment in Overweight and Obese Older Individuals With Prediabetes[J].Diabetes Care.2013(10)
  • 9M. Wenten,J. A. Gaebler,M. Hussein,E. M. Pelletier,D. B. Smith,P. Girase,R. A. Noel,D. K. Braun,G. L. Bloomgren.Relative risk of acute pancreatitis in initiators of exenatide twice daily compared with other anti‐diabetic medication: a follow‐up study[J].Diabetic Medicine.2012(11)
  • 10S. Herzberg‐Sch?fer,M. Heni,N. Stefan,H.‐U. H?ring,A. Fritsche.Impairment of GLP1 ‐induced insulin secretion: role of genetic background, insulin resistance and hyperglycaemia[J].Diabetes Obes Metab.2012

共引文献18

同被引文献150

引证文献10

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部